Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
| Brand name | TIZANIDINE |
| Generic name | TIZANIDINE |
| Active ingredient(s) | TIZANIDINE HYDROCHLORIDE |
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 55111-180-15 |
| Full product label | Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15 |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | USA Nationwide |
| Quantity | 38,952 bottles |
| Recall initiated | 2024-01-02 |
| Report date | 2024-01-17 |
| Recall completed | — |
| Recall number | D-0223-2024 |
| Classification | Class II |
| FDA status | Completed |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗